Cross Country Healthcare, Inc. (NASDAQ:CCRN – Get Rating) – Equities researchers at Barrington Research issued their Q1 2022 earnings per share estimates for Cross Country Healthcare in a report released on Monday, April 11th. Barrington Research analyst K. Steinke anticipates that the business services provider will earn $1.42 per share for the quarter. Barrington Research also issued estimates for Cross Country Healthcare’s Q3 2022 earnings at $0.83 EPS and Q4 2022 earnings at $0.70 EPS.
Other analysts also recently issued reports about the company. Zacks Investment Research raised Cross Country Healthcare from a “hold” rating to a “strong-buy” rating and set a $22.00 price target for the company in a research report on Friday, January 21st. Jefferies Financial Group raised Cross Country Healthcare from a “hold” rating to a “buy” rating and raised their target price for the stock from $18.00 to $27.00 in a research report on Thursday, January 27th. StockNews.com started coverage on Cross Country Healthcare in a research report on Thursday, March 31st. They issued a “hold” rating for the company. Finally, Benchmark raised their target price on Cross Country Healthcare from $33.00 to $42.00 and gave the stock a “buy” rating in a research report on Thursday, February 24th. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $28.14.
Shares of CCRN opened at $21.30 on Wednesday. The company has a current ratio of 2.54, a quick ratio of 2.54 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $810.74 million, a price-to-earnings ratio of 6.03, a PEG ratio of 1.13 and a beta of 1.06. The stock has a 50 day moving average of $21.33 and a 200 day moving average of $22.86. Cross Country Healthcare has a 12 month low of $12.47 and a 12 month high of $30.40.
Cross Country Healthcare (NASDAQ:CCRN – Get Rating) last issued its quarterly earnings results on Wednesday, February 23rd. The business services provider reported $1.40 EPS for the quarter, beating the Zacks’ consensus estimate of $1.35 by $0.05. The company had revenue of $640.68 million during the quarter, compared to the consensus estimate of $611.54 million. Cross Country Healthcare had a return on equity of 52.08% and a net margin of 7.87%. Cross Country Healthcare’s revenue was up 197.2% on a year-over-year basis. During the same period last year, the business posted $0.19 earnings per share.
In related news, CFO William J. Burns sold 10,000 shares of Cross Country Healthcare stock in a transaction on Monday, March 7th. The stock was sold at an average price of $20.54, for a total transaction of $205,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Susan E. Ball sold 17,458 shares of Cross Country Healthcare stock in a transaction on Monday, March 7th. The shares were sold at an average price of $20.72, for a total value of $361,729.76. The disclosure for this sale can be found here. 5.60% of the stock is owned by company insiders.
A number of large investors have recently bought and sold shares of the stock. Wellington Management Group LLP lifted its stake in Cross Country Healthcare by 138.4% during the third quarter. Wellington Management Group LLP now owns 2,332,175 shares of the business services provider’s stock worth $49,536,000 after purchasing an additional 1,353,750 shares during the last quarter. Divisadero Street Capital Management LP bought a new stake in Cross Country Healthcare during the fourth quarter worth about $10,629,000. Congress Asset Management Co. MA bought a new stake in Cross Country Healthcare during the fourth quarter worth about $8,760,000. Balyasny Asset Management LLC bought a new stake in Cross Country Healthcare during the third quarter worth about $5,862,000. Finally, Millennium Management LLC lifted its stake in Cross Country Healthcare by 260.4% during the third quarter. Millennium Management LLC now owns 287,510 shares of the business services provider’s stock worth $6,107,000 after purchasing an additional 207,733 shares during the last quarter. 90.96% of the stock is owned by institutional investors.
About Cross Country Healthcare (Get Rating)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services.
Receive News & Ratings for Cross Country Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cross Country Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.